162 related articles for article (PubMed ID: 24885902)
1. Long-term survey of a syringe-dispensing machine needle exchange program: answering public concerns.
Duplessy C; Reynaud EG
Harm Reduct J; 2014 May; 11():16. PubMed ID: 24885902
[TBL] [Abstract][Full Text] [Related]
2. Staff perceptions of syringe dispensing machines in Australia: a pilot study.
Islam MM; Conigrave KM; Stern T
Subst Use Misuse; 2009; 44(4):490-501. PubMed ID: 19283622
[TBL] [Abstract][Full Text] [Related]
3. Analysis of four syringe dispensing machine point-of-access data 2017-2020 in Melbourne, Australia: machine utilisation and client demographics.
Kerr P; Cossar RD; Livingston M; Jacka D; Dietze P; O'Keefe D
Harm Reduct J; 2022 Dec; 19(1):144. PubMed ID: 36544124
[TBL] [Abstract][Full Text] [Related]
4. Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
O'Keefe D; Livingston M; Cossar RD; Kerr P; Jacka D; Dietze P
Harm Reduct J; 2022 Sep; 19(1):101. PubMed ID: 36071500
[TBL] [Abstract][Full Text] [Related]
5. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
[TBL] [Abstract][Full Text] [Related]
6. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.
Islam M; Stern T; Conigrave KM; Wodak A
Drug Alcohol Rev; 2008 Jan; 27(1):13-9. PubMed ID: 18034377
[TBL] [Abstract][Full Text] [Related]
7. The impact of an automatic syringe dispensing machine in inner-city Sydney, Australia: No evidence of a 'honey-pot' effect.
Day CA; White B; Haber PS
Drug Alcohol Rev; 2016 Sep; 35(5):637-43. PubMed ID: 27073122
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of a trial of syringe vending machines in Canberra, Australia.
McDonald D
Int J Drug Policy; 2009 Jul; 20(4):336-9. PubMed ID: 18790622
[TBL] [Abstract][Full Text] [Related]
9. [Community collection of syringes by parenteral drug users complementary to syringe exchange programs].
Bechich S; Martínez M; Llorella G; Rodés A; De Andrés M; Delás J
Gac Sanit; 2001; 15(4):353-5. PubMed ID: 11578566
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
Islam M; Wodak A; Conigrave KM
Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
[TBL] [Abstract][Full Text] [Related]
11. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction product distribution in British Columbia.
Harvard SS; Hill WD; Buxton JA
Can J Public Health; 2008; 99(6):446-50. PubMed ID: 19149383
[TBL] [Abstract][Full Text] [Related]
13. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
White B; Haber PS; Day CA
Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
[TBL] [Abstract][Full Text] [Related]
14. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.
Beletsky L; Grau LE; White E; Bowman S; Heimer R
Addiction; 2011 Feb; 106(2):357-65. PubMed ID: 21054615
[TBL] [Abstract][Full Text] [Related]
15. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
[TBL] [Abstract][Full Text] [Related]
17. The impact of a 24-hour syringe dispensing machine on a face-to-face needle and syringe program and targeted primary healthcare clinic.
Uthurralt N; McGlinn A; O'Donnell M; Haber PS; Day CA
Aust N Z J Public Health; 2022 Aug; 46(4):524-526. PubMed ID: 35679052
[TBL] [Abstract][Full Text] [Related]
18. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
[TBL] [Abstract][Full Text] [Related]
19. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
[TBL] [Abstract][Full Text] [Related]
20. The legality of selling or giving syringes to injection drug users.
Burris S; Vernick JS; Ditzler A; Strathdee S
J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
